• Genetically Encoded NADH/NAD+ Redox Biosensor Advances Bacte

  2026-05-06

  Liu et al. engineered a ratiometric biosensor enabling high-throughput, noninvasive measurement of NADH/NAD+ ratios in live bacteria, overcoming the limitations of traditional redox assays. This innovation facilitates new approaches to dissect and manipulate bacterial energy metabolism and redox balance.

• Lopinavir (ABT-378): Precision Protease Inhibition for Trans

  2026-05-05

  This thought-leadership article explores Lopinavir (ABT-378) as a model compound for translational HIV and cross-viral research. We blend mechanistic insights into protease inhibition, mutation resilience, and serum stability with strategic guidance for researchers bridging HIV drug resistance assays and broader antiviral applications. Anchored in recent evidence—including MERS-CoV screening findings—and referencing both APExBIO’s product and leading content assets, we map out the critical advantages, protocol considerations, and visionary outlooks for leveraging Lopinavir in next-generation antiretroviral research.

• Phosphatase Inhibitor Cocktail: Precision in Phosphorylation

  2026-05-05

  Unlock robust protein phosphorylation preservation with the APExBIO Phosphatase Inhibitor Cocktail (2 Tubes, 100X). This dual-tube system enhances data reliability across immunoblotting, kinase assays, and mass spectrometry by targeting both serine/threonine and tyrosine phosphatases. Streamline your workflow and safeguard critical PTM states even in challenging experimental settings.

• Calpain Inhibition Mitigates Offspring Cognitive Impairment

  2026-05-04

  The referenced study identifies excessive calpain activation as a driver of cognitive deficits in offspring following maternal non-obstetric surgery, mediated by suppression of the BDNF/TrkB pathway. Pharmacological inhibition using MDL 28170 partially restored hippocampal structure and cognitive function, highlighting calpain as a therapeutic target for neuroprotection in perinatal injury models.

• Calpain Inhibitor I, ALLN: Technical Guidance and Best Pract

  2026-05-04

  Calpain Inhibitor I, ALLN is a potent inhibitor for calpain and cathepsin proteases, supporting targeted research in apoptosis, inflammation, and ischemia-reperfusion injury models. It enables precise control of protease activity; however, users should avoid employing it in diagnostic or clinical settings and ensure proper solubilization and storage for reliable results.

• Ziprasidone HCl: Mechanistic Leverage for Translational Impa

  2026-05-03

  Ziprasidone Hydrochloride (Ziprasidone HCl) is emerging as a unique research tool at the interface of neuropharmacology and oncology, offering dual mechanisms—serotonin/dopamine receptor antagonism and GOT1 inhibition—that are reshaping translational strategies. This thought-leadership article provides mechanistic context, reviews critical permeability and efficacy data, and outlines strategic guidance for researchers seeking to bridge neuroscience and cancer metabolism. By integrating fresh evidence, highlighting advanced formulation approaches, and situating APExBIO’s offering within the evolving research landscape, we deliver actionable insight for investigators aiming to unlock cross-domain innovation.

• Dual-Action p38α MAPK Inhibitors Promote Dephosphorylation

  2026-05-02

  This study reveals that certain p38α MAP kinase inhibitors not only block kinase activity but also accelerate dephosphorylation of the activation loop via phosphatase WIP1. Structural analysis explains how inhibitor-induced conformations enhance phosphatase access, offering a new paradigm for achieving specificity in kinase-targeted research.

• EdU Imaging Kits: Transforming Cell Proliferation Assays

  2026-05-02

  EdU Imaging Kits (HF488) from APExBIO revolutionize DNA synthesis measurement for cell proliferation, offering unmatched sensitivity and workflow efficiency. Their click chemistry approach preserves cell integrity and streamlines analysis for both microscopy and flow cytometry, making them indispensable in modern translational research.

• Dual Glutamate Receptor Blockade Mitigates Soman Neurotoxici

  2026-05-01

  The referenced study demonstrates that dual AMPA/NMDA receptor antagonism with IEM-1925 offers superior seizure control, neuroprotection, and cognitive preservation in a rat model of soman-induced status epilepticus. These findings advance the translational potential of glutamate receptor blockade for neuroprotection against organophosphorus nerve agent exposure.

• Cy5 Maleimide for Precision Protein Labeling: Workflows & In

  2026-04-30

  Cy5 maleimide (non-sulfonated) enables site-specific, high-sensitivity cysteine labeling for advanced protein imaging and condensate studies. This guide translates the latest research and expert workflows into actionable protocols, troubleshooting, and experimental upgrades that maximize the reagent's impact in complex biochemical assays.

• Mitigating Pollen Interference in Fluorescence-Based Bioaero

  2026-04-30

  This study introduces a systematic workflow to identify and remove pollen spectral interference in excitation–emission matrix (EEM) fluorescence spectroscopy, enhancing the accuracy of hazardous bioaerosol classification. By integrating advanced spectral preprocessing and random forest machine learning, the approach enables more reliable discrimination of bacterial pathogens and biotoxins in the presence of pollen, supporting public health surveillance.

• Zoledronic Acid: Mechanistic Insights for Translational Onco

  2026-04-29

  This thought-leadership article explores the mechanistic role of Zoledronic Acid—a potent nitrogen-containing bisphosphonate—in cancer research and its emerging implications in translational studies. Integrating evidence from recent multiomics analyses of aortic disease and established oncological models, the article provides strategic guidance for researchers seeking to bridge molecular mechanisms with therapeutic innovation. Key protocol parameters, workflow recommendations, and practical considerations for Zoledronic Acid use are included, with a forward-looking perspective on the evolving landscape of ECM-targeted interventions.

• Ziprasidone Hydrochloride: GOT1 Inhibition and Tumor Redox D

  2026-04-29

  Explore how Ziprasidone HCl targets glutamine metabolism via GOT1 inhibition to disrupt tumor redox balance. This in-depth analysis reveals mechanistic insights and protocol guidance beyond existing application-focused articles.

• Metabolic Alterations in Posterior Fossa Malignancies: Beyon

  2026-04-28

  This article examines the doctoral study by Derek Dang, which advances our understanding of metabolic reprogramming in posterior fossa malignancies beyond the classical Warburg effect. The research leverages advanced molecular techniques to dissect complex metabolic shifts, providing new directions for targeted interventions and phosphoproteomic workflows.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-04-28

  The Hoechst 33342/PI Double Staining Kit enables precise discrimination of apoptotic, necrotic, and viable cells in fluorescence-based assays, supporting basic research workflows. It is not intended for diagnostic or medical use, and its protocol is optimized for microscopy-based cell death analysis.

449 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page